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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comScientiﬁc), and 60MHz IVUS (Kodama, ACIST Medical Systems) in a saline-ﬁlled
tank at 37C. In each diameter phantom model, mean lumen diameter (mean LD) was
obtained at 10 cross-sections randomly selected from 3 repeated automated pullbacks.
OCT images were obtained under the system setting for saline ﬂush. IVUS mea-
surements were adjusted to compensate for the difference in the speed of sound in
saline vs. blood.
Results: Overall, OCT and 40MHz IVUS consistently overestimated mean LD
(0.070.03 and 0.150.03 mm, respectively), while 60MHz IVUS showed slight
underestimation (-0.080.03 mm). In all diameter models, absolute differences in
mean LD were signiﬁcantly larger in 40MHz IVUS than OCT and 60MHz IVUS
(p< 0.01 for all). 60MHz IVUS was comparable or superior to OCT in phantoms
S3.04 mm, whereas OCT showed excellent near-ﬁeld precision in small diameter
phantoms (&2.03 mm).Mild calciﬁcation Heavy calciﬁcation
Arc of calciﬁcation (0x90 ) Arc of calciﬁcation (90x360 )
EES (N¼22) BES (N¼17) P EES (N¼39) BES (N¼34) P
Mean arc of calciﬁcation ( ) 55.6820.22 55.3414.11 0.954 174.2269.74 190.9091.21 0.390
DM (%) 13.6 17.6 0.739 53.8 61.8 0.502
Pre % diameter stenosis 69.2 69.6 0.916 69.6 69.1 0.890
Just after stenting
Minimum/Estimated stent
diameter (mm)
0.764 0.781 0.388 0.713 0.750 0.111
Minimum/Estimated CSA
(mm2)
0.713 0.773 0.044 0.651 0.748 <0.01
Symmetry index 0.873 0.876 0.873 0.813 0.862 <0.01
Final resul
Minimum/Estimated stent
diameter (mm)
0.793 0.837 0.07 0.741 0.789 0.037
Minimum/Estimated CSA
(mm2)
0.764 0.784 0.516 0.731 0.792 0.011
Symmetry index 0.878 0.881 0.907 0.843 0.871 0.057Conclusions: The novel 60MHz IVUS system signiﬁcantly improves the quantitative
accuracy of conventional 40MHz IVUS, demonstrating clinically acceptable precision
across the wide range of lumen diameter from 1.5 to 5.0 mm.
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Background: Although it has been recognized that thin strut cobalt chromium
everolimus-eluting stent (EES; Xience) is associated with less target lesion failure, it
has lower radial force, and it had failed to prove superiority to thick strut paclitaxel-
eluting stent in diabetes in some studies. We speculated that stent underexpansion in
calciﬁed lesions which are frequently observed in diabetes may be one of reasons, and
investigated stent expansion between two different types of stent platform in calciﬁed
lesions using intravascular ultrasound (IVUS).B106 JACC Vol 64/11/Suppl B jMethods: One hundred twelve lesions (61 EES and 51 thick stainless platform bio-
limus-eluting stent (BES; Nobori) treated by IVUS-guided elective PCI were
recruited. With pre-procedural IVUS, optimal stent size and length were determined
and degree of calciﬁcation was evaluated. After stenting, IVUS was repeated and stent
diameter and cross-sectional area (CSA) were measured. If stent expansion was
inadequate, post dilatation was performed and again IVUS was performed. Quanti-
tative coronary angiography (QCA) and IVUS ﬁndings were compared with estimated
diameter and CSA calculated from deployed pressure and each compliance chart
(Measured/Estimated ratio).
Results: Immediately after stenting in moderate/severe calciﬁed lesions (arc of
calciﬁcation > 90 degree), underexpansion of EES compared to BES was observed,
and the trend continued after post dilatation.Conclusions: There is a signiﬁcant difference of expansion between thin cobalt and
thick stainless stents in calciﬁed lesions. When thin strut stent is deployed in calciﬁed
lesions, careful evaluation of stent expansion and adequate post dilatation may be
necessary.Imaging Intravascular - OCT
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Background: Lack of re-endothelialisation and neointimal coverage on stent struts
has been put forward as the main underlying mechanism leading to late stent
thrombosis. Incomplete Stent Apposition (ISA) has been frequently observed in pa-
tients with very late stent thrombosis after DES implantation, suggesting a role of ISA
in the pathogenesis of this adverse event. The aim of this study was to evaluate the
impact of different degrees of ISA severity on abnormal shear rate and healing
response with coverage, due to its potential implications for stent optimization in
clinical practice.
Methods: We characterized ﬂow proﬁle and shear distribution in different cases of
ISA with increasing strut-wall detachment distance (ranging from 100 mm to 500 mm).
Protruding strut and strut malapposed with moderate detachment (ISA detachment
distance < 100mm) have minimal disturbance to blood ﬂow as compared with ﬂoating
strut that has more signiﬁcant ISA distance. In-vivo impact on strut coverage was
assessed retrospectively using Optical Coherence Tomography evaluation on 72 stents
(48 patients) sequentially at baseline and after 6 months follow-up.September 13–17, 2014 j TCT Abstracts/Imaging Intravascular - OCT
